1. Home
  2. Author
  3. Saylan ML

Saylan ML

References (2)

Title : Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes - D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81
Author(s) : D'Alessio DA , Denney AM , Hermiller LM , Prigeon RL , Martin JM , Tharp WG , Saylan ML , He Y , Dunning BE , Foley JE , Pratley RE
Ref : J Clinical Endocrinology Metab , 94 :81 , 2009
Abstract :
PubMedSearch : D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81
PubMedID: 18957505

Title : The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study - Vella_2008_Clin.Endocrinol.(Oxf)_69_737
Author(s) : Vella A , Bock G , Giesler PD , Burton DB , Serra DB , Saylan ML , Deacon CF , Foley JE , Rizza RA , Camilleri M
Ref : Clinical Endocrinology (Oxf) , 69 :737 , 2008
Abstract :
PubMedSearch : Vella_2008_Clin.Endocrinol.(Oxf)_69_737
PubMedID: 18331607